AdvanDx Overview

AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available in hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.

PNA FISH™ and EVIGENE™ tests provide rapid...More»

AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available in hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.

PNA FISH™ and EVIGENE™ tests provide rapid identification results for bacteria and yeast to support appropriate antibiotic therapy and improve overall patient care. PNA FISH is available for in vitro diagnostic use (IVD) in the United States, Canada and Europe while EVIGENE is available for research use only (RUO) in the United States and for in vitro diagnostic use in Europe. (Please refer to the individual products for information on the regulatory status)«Less